Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

KETAMINE 500 MG/10 ML VIAL

Ketamine Hydrochloride
$0.5215per ML
High Outlier
DEA Schedule CIII

Strength

50 mg/mL

Manufacturer

Hospira Inc.

NDC

00409205310

Classification

Generic

Dosage Form

INJECTION, SOLUTION, CONCENTRATE

Route

INTRAMUSCULAR; INTRAVENOUS

Last Updated

4/22/2026

Active Ingredients

KETAMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074549

On Market Since

11/30/2004

Pharmacological Classes

General Anesthesia
General Anesthetic

Price History

1W

0.0%

1M

+0.0%

3M

-2.2%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-2.2%

Generic Alternatives

3 alternatives • Same active ingredient

KETAMINE 500 MG/10 ML VIAL
Generic
72572032010•Civica, Inc.
$0.5215
KETAMINE 500 MG/10 ML VIAL
Generic
00143950810•Hikma Pharmaceuticals USA Inc.
$0.5215
KETAMINE 500 MG/10 ML VIAL
Generic
25021068310•Sagent Pharmaceuticals
$0.5215

Related Drugs

Same classification

PROPOFOL 200 MG/20 ML VIAL
Generic
00409601025•Hospira Inc.
$0.1750
per ML
PROPOFOL 200 MG/20 ML VIAL
Generic
25021060820•Sagent Pharmaceuticals
$0.1750
per ML
PROPOFOL 200 MG/20 ML VIAL
Generic
43598026525•Dr. Reddy's Laboratories Inc.
$0.1750
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
55150043910•Eugia US LLC
$0.5215
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
65219018810•Fresenius Kabi USA, LLC
$0.5215
per ML
KETAMINE 500 MG/5 ML VIAL
Generic
00409004010•Hospira Inc.
$1.5655
per ML
KETAMINE 500 MG/5 ML VIAL
Generic
65219018605•Fresenius Kabi USA, LLC
$1.5655
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy